Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 3;23(12):3186.
doi: 10.3390/molecules23123186.

Natural Negative Allosteric Modulators of 5-HT₃ Receptors

Affiliations
Review

Natural Negative Allosteric Modulators of 5-HT₃ Receptors

Lina T Al Kury et al. Molecules. .

Abstract

Chemotherapy-induced nausea and vomiting (CINV) remain the most common and devastating side-effects associated with cancer chemotherapy. In recent decades, several lines of research emphasize the importance of 5-hydroxytryptamine3 (5-HT3; serotonin) receptors in the pathogenesis and treatment of CINV. 5-HT₃ receptors are members of ligand-gated ion channels that mediate the rapid and transient membrane-depolarizing effect of 5-HT in the central and peripheral nervous system. These receptors play important roles in nausea and vomiting, as well as regulation of peristalsis and pain transmission. The development of antagonists for 5-HT₃ receptor dramatically improved the treatment of CINV in cancer patients. In fact, the most common use of 5-HT₃ receptor antagonists to date is the treatment of nausea and vomiting. In recent years, there has been an increasing tendency to use natural plant products as important therapeutic entities in the treatment of various diseases. In this article, we examined the results of earlier studies on the actions of natural compounds on the functional properties of 5-HT₃ receptors. It is likely that these natural modulators of 5-HT₃ receptors can be employed as lead structures for the synthesis of therapeutic agents for treating CINV in future clinical studies.

Keywords: 5-hydroxytryptamine3 receptor antagonists; 5-hydroxytryptamine3 receptors; chemotherapy-induced nausea and vomiting; negative allosteric modulators.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Natural negative allosteric modulators of 5-HT3 receptor.

References

    1. Janelsins M.C., Tejani M.A., Kamen C., Peoples A.R., Mustian K.M., Morrow G.R. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert. Opin. Pharmacother. 2013;14:757–766. doi: 10.1517/14656566.2013.776541. - DOI - PMC - PubMed
    1. Haniadka R., Popouri S., Palatty P.L., Arora R., Baliga M.S. Medicinal plants as antiemetics in the treatment of cancer: A review. Integr. Cancer Ther. 2012;11:18–28. doi: 10.1177/1534735411413266. - DOI - PubMed
    1. Navari R.M. Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents. Drugs. 2013;73:249–262. doi: 10.1007/s40265-013-0019-1. - DOI - PubMed
    1. Hesketh P.J., Kris M.G., Basch E., Bohlke K., Barbour S.Y., Clark-Snow R.A., Danso M.A., Dennis K., Dupuis L.L., Dusetzina S.B., et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. 2017;35:3240–3261. doi: 10.1200/JCO.2017.74.4789. - DOI - PubMed
    1. Gilmore J., D’Amato S., Griffith N., Schwartzberg L. Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists. Cancer Manag. Res. 2018;10:1827–1857. doi: 10.2147/CMAR.S166912. - DOI - PMC - PubMed

MeSH terms